Who Is Elizabeth Blackwell?
Why Google is celebrating the pioneer of medical and feminist history.
Send us a link
Government Wants to Speed Gene-Editing Therapies to Patients
The US biomedical research agency NIH says it is dedicating $190 million over the next six years to researchers conducting gene-editing experiments, such as those with the powerful CRISPR technique.
Broad Institute Takes a Hit in European CRISPR Patent Struggle
A decision from the European Patent Office (EPO) has put the Broad Institute in Cambridge, Massachusetts, on shaky ground with its intellectual property claims to the gene-editing tool CRISPR.
Why Does America Still Have so few Female Doctors?
As a culture and a profession, medicine continues to systematically disadvantage women physicians at every stage of their careers.
Representing A "Revolution": How the Popular Press Has Portrayed Personalized Medicine
500,000 Britons’ Genomes Will Be Public by 2020, Transforming Drug Research
500,000 Britons’ Genomes Will Be Public by 2020, Transforming Drug Research
Six drug firms are paying to sequence the genes of every volunteer in the UK Biobank.
Precision Medical Treatments Have A Quality Control Problem
The goal is to customize treatments for cancer and other diseases to a patient's own biology. But something as simple as failing to take care of tissue samples en route to the lab can derail that.
Military Agency Invests $100m in Genetic Extinction Technologies
Technology could be used to wipe out malaria carrying mosquitos or other pests but UN experts say fears over possible military uses and unintended consequences strengthen case for a ban.
A Failure to Heal
When a clinical trial falters, doctors find themselves sifting through the rubble.
To Cut Drug Prices, Academy of Sciences Tells the Government to Negotiate With Manufacturers
To Cut Drug Prices, Academy of Sciences Tells the Government to Negotiate With Manufacturers
The National Academy of Sciences called on the federal government to make drastic policy changes to bring down the cost of prescription medicines.
What Do We Know About Grant Peer Review in the Health Sciences?
What Do We Know About Grant Peer Review in the Health Sciences?
Peer review decisions award >95% of academic medical research funding, so it is crucial to understand how well they work and if they could be improved.
A Systematic Review of Sample Size and Power in Leading Neuroscience Journals
A Systematic Review of Sample Size and Power in Leading Neuroscience Journals
Adequate sample size is key to reproducible research findings: low statistical power can increase the probability that a statistically significant result is a false positive.
Research Health Needs a Dedicated Group
A US Research Integrity Advisory Board is long overdue. Such a leadership body would mitigate bad practices and strengthen good research.
Dissipative Adaptation, The Origins of Life and Deep Learning
In this piece, I will explain how the explanation of the emergence of life could also explain the mechanism of Deep Learning.
European Medicines Agency Will Move to Amsterdam
London’s loss, as a result of Brexit vote, is lamented by U.K. researchers
First Digital Pill Approved
The medicine, an antipsychotic drug, has a sensor that will show doctors whether and when patients are taking it. Other medicines will follow, experts say.
NIH Awards to Test Ways to Store, Access, Share, and Compute on Biomedical Data in the Cloud
NIH Awards to Test Ways to Store, Access, Share, and Compute on Biomedical Data in the Cloud
NIH Data Commons Pilot Phase to seek best practices for developing and managing a data commons.
What Happens When You Put 500,000 People's DNA Online
Huge genetic databases are changing how scientists study disease.
Join the Disruptors of Health Science
Thomas Insel's biggest lesson from his shift from NIMH director to Silicon Valley entrepreneur: academic and technology company researchers should partner up.
Is Health Care Ready for Routine DNA Screening? A Massive New Trial Will Find Out
More than 400 Pennsylvanians have already learned of disease mutations.
‘Health Valley’ Gets even Healthier
ADC Therapeutics, a Swiss start-up that specialises in cutting-edge cancer drugs, has raised almost CHF200 million ($200 million) in private funds.
Dearly Departed Languages
Why Greek and Latin medical terminology is better off dead.
The Rise and Fall and Rise again of 23andMe
How Anne Wojcicki led her company from the brink of failure to scientific pre-eminence.
Uganda Removes Key Hurdle to GM Crops
New law would allow commercial planting of transgenic varieties in Uganda.
How Do We Define the Policy Impact of Public Health Research?
A systematic review
Are Preprints the Future of Biology?
Biologists are posting unreviewed manuscripts in record numbers. But many are still not sure it's a good idea. A survival guide for scientists.
Ambitious Neuroscience Project to Probe How the Brain Makes Decisions
Combining expertise from 21 labs in Europe and the US, the International Brain Laboratory will attempt to answer one of the greatest mysteries of all time.
Too Few Antibiotics in Pipeline to Tackle Global Drug-Resistance Crisis
Too Few Antibiotics in Pipeline to Tackle Global Drug-Resistance Crisis
Nowhere near enough new drugs are currently in development says a WHO report, which calls for urgent investment and responsible use of existing antibiotics.
Researchers Unite in Quest for ‘Standard Model’ of the Brain
Modelled on big physics projects, the International Brain Lab will bring together some of the world’s pre-eminent neuroscientists to probe a single behaviour.
×